Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 931073, 8 pages
http://dx.doi.org/10.1093/ecam/nep012
Original Article

Preventive Effect of Boiogito on Metabolic Disorders in the TSOD Mouse, a Model of Spontaneous Obese Type II Diabetes Mellitus

1Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20, Shin-machi, Nishi-Tokyo-shi, Tokyo 202-8585, Japan
2Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
3Department of Clinical Pharmacy, Graduate School of Natural Science and Technology, and Department of Hospital Pharmacy, School of Medicine, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8641, Japan

Received 8 September 2008; Accepted 12 January 2009

Copyright © 2011 Tsutomu Shimada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Matsuzawa, “The metabolic syndrome and adipocytokines,” FEBS Letters, vol. 580, no. 12, pp. 2917–2921, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. G. M. Reaven, “The metabolic syndrome: is this diagnosis necessary?” American Journal of Clinical Nutrition, vol. 83, no. 6, pp. 1237–1247, 2006. View at Google Scholar · View at Scopus
  3. National Health and Nutrition Examination Survey 2004 by the Ministry of Health, Labour and Welfare, May 2007, http://www.mhlw.go.jp/.
  4. K. Mitani, “Metabolic syndrome and Kampo therapy,” Kampo & the Newest Therapy, vol. 14, pp. 43–47, 2005 (Japanese). View at Google Scholar
  5. M. Tsunakawa, T. Shimada, W. Suzuki et al., “Preventive effects of Daisaikoto on metabolic disorders in spontaneous obese type II diabetes mice,” Journal of Traditional Chinese Medicine, vol. 23, pp. 216–223, 2006. View at Google Scholar
  6. T. Shimada, T. Kudo, T. Akase, and M. Aburada, “Preventive effects of bofutsushosan on obesity and various metabolic disorders,” Biological and Pharmaceutical Bulletin, vol. 31, no. 7, pp. 1362–1367, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Suzuki, S. Iizuka, M. Tabuchi et al., “A new mouse model of spontaneous diabetes derived from ddY strain,” Experimental Animals, vol. 48, no. 3, pp. 181–189, 1999. View at Google Scholar · View at Scopus
  8. S. Iizuka, W. Suzuki, M. Tabuchi et al., “Diabetic complications in a new animal model (TSOD mouse) of spontaneous NIDDM with obesity,” Experimental Animals, vol. 54, no. 1, pp. 71–83, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Takahashi, M. Tabuchi, W. Suzuki et al., “Insulin resistance and low sympathetic nerve activity in the Tsumura Suzuki obese diabetic mouse: a new model of spontaneous type 2 diabetes mellitus and obesity,” Metabolism, vol. 55, pp. 1664–9, 2006. View at Google Scholar
  10. I. Hirayama, Z. Yi, S. Izumi et al., “Genetic analysis of obese diabetes in the TSOD mouse,” Diabetes, vol. 48, no. 5, pp. 1183–1191, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Mizutani, H. Gomi, I. Hirayama, and T. Izumi, “Chromosome 2 locus Nidd5 has a potent effect on adiposity in the TSOD mouse,” Mammalian Genome, vol. 17, no. 5, pp. 375–384, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Suzuki, S. Iizuka, M Hiruta et al., “General behavior, motion and sensory role in NIDDM model TSOD mice,” Diabetes Frontier, vol. 10, pp. 603–604, 1999 (Japanese), (in Japanese). View at Google Scholar
  13. L. A. Edwards, J. M. Bugaresti, and A. C. Buchholz, “Visceral adipose tissue and the ratio of visceral to subcutaneous adipose tissue are greater in adults with than in those without spinal cord injury, despite matching waist circumferences,” American Journal of Clinical Nutrition, vol. 87, pp. 600–607, 2008. View at Google Scholar
  14. H. Toshihiko, The Lesson for Kampo Therapy, vol. 27, Kanehara & Co., Ltd, Tokyo, Japan, 1995.
  15. A. Tsumura, KAMPO: How the Japanese Updated Traditional Herbal Medicine, Japan Publications, Tokyo, Japan, 1991.
  16. T. Tsutsumi, S. Kobayashi, Y. Y. Liu, and H. Kontani, “Anti-hyperglycemic effect of fangchinoline isolated from Stephania tetrandra Radix in streptozotocin-diabetic mice,” Biological and Pharmaceutical Bulletin, vol. 26, no. 3, pp. 313–317, 2003. View at Google Scholar · View at Scopus
  17. Y. L. Yuan, K. Shinjiro, and K. Taiki T Hitoshi, “Combined effects of Stephania Radix and Astragali Radix in antihyperglycemic action of Boi-ogi-to (fang-ji-huang-qi-tang) in streptozotocin-induced diabetic mice,” Journal of Traditional Chinese Medicine, vol. 17, pp. 253–260, 2000. View at Google Scholar
  18. J.-I. Yamakawa, J. Moriya, T. Takahashi et al., “A kampo medicine, boi-ogi-to, inhibits obesity in ovariectomized rats,” Evidence-Based Complementary and Alternative Medicine, vol. 7, no. 1, pp. 87–95, 2010. View at Publisher · View at Google Scholar
  19. A. Morishima, “Experience of Kampo therapy against obesity,” Journal of Parenteral and Enteral Nutrition, vol. 7, pp. 472–473, 1985. View at Google Scholar
  20. L.-K. Han, X.-J. Gong, S. Kawano, M. Saito, Y. Kimura, and H. Okuda, “Antiobesity actions of Zingiber officinale Roscoe,” Yakugaku Zasshi, vol. 125, no. 2, pp. 213–217, 2005 (Japanese). View at Publisher · View at Google Scholar · View at Scopus
  21. U. Bhandari, J. N. Sharma, and R. Zafar, “The protective action of ethanolic ginger (Zingiber officinale) extract in cholesterol fed rabbits,” Journal of Ethnopharmacology, vol. 61, no. 2, pp. 167–171, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Tanabe, Y.-D. Chen, K. Saito, and Y. Kano, “Cholesterol biosynthesis inhibitory component from Zingiber officinale Roscoe,” Chemical and Pharmaceutical Bulletin, vol. 41, no. 4, pp. 710–713, 1993. View at Google Scholar · View at Scopus
  23. H. Takii, T. Kometani, T. Nishimura, T. Nakae, S. Okada, and T. Fushiki, “Antidiabetic effect of glycyrrhizin in genetically diabetic KK-Ay mice,” Biological and Pharmaceutical Bulletin, vol. 24, no. 5, pp. 484–487, 2001. View at Publisher · View at Google Scholar · View at Scopus